Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic (“lazy”) eye.
MIT researchers identified three cognitive skills that we use to infer what someone really means.
MIT researchers discover how an immune system molecule triggers neurons to shut down social behavior in mice modeling infection.
A new atlas charts the diversity of an influential cell type in the brains of mice and marmosets.
Whether they walk on two, four, or six legs, animals maintain stability by monitoring their body position and correcting errors with every step.
MIT neuroscientists find a surprising parallel in the ways humans and new AI models solve complex problems.
Seven speakers from around the country convened at MIT to describe some of the latest research on the neural mechanisms that we need to survive.
Through the MIT Consciousness Club, professors Matthias Michel and Earl Miller are exploring how neurological activity gives rise to human experience.
Five volunteers received 40Hz stimulation for around two years after an early-stage clinical study. Those with late-onset Alzheimer’s performed better on assessments than Alzheimer’s patients outside the trial.
Cultured from induced pluripotent stem cells, “miBrains” integrate all major brain cell types and model brain structures, cellular interactions, activity, and pathological features.
While most states mandate screenings to guide early interventions for children struggling with reading, many teachers feel underprepared to administer and interpret them.
Scientists identified how circuit connections in fruit flies tune to the right size and degree of signal transmission capability. Understanding this could lead to a way to tweak abnormal signal transmission in certain disorders.
Media Lab PhD student Kimaya Lecamwasam researches how music can shape well-being.
The Rare Brain Disorders Nexus aims to accelerate the development of novel therapies for a spectrum of uncommon brain diseases.
Speakers at MIT’s Aging Brain Initiative symposium described how immune system factors during aging contribute to Alzheimer’s, Parkinson’s and other conditions. The field is leveraging that knowledge to develop new therapies.